Clinical Research Detail Title Of Study A clinical study to compare effects and safety Of recombinant Insulin Glargine manufactured by Biocon Ltd Compared to marketed Glargine (Lantus) In patients of Type 1 Diabetes Mellitus. Disease Condition Type 1 Diabetes Mellitus Phase of Trial Phase-3 Discipline Diabetology Start date of Trial 3/11/2008 Closing Date of Trial 3/11/2008 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]